San Anselmo, CA, United States of America

Eugene Michal

This inventor holds 1 USPTO granted patent. Top assignee: Efemoral Medical Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugene Michal. Retrieved from https://idiyas.com/inventor/eugene-michal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eugene Michal and Bioresorbable Intravascular Stents.

Introduction

Eugene Michal is an inventor associated with San Anselmo, California. His patent work concerns bioresorbable intravascular stents designed to help maintain or enhance blood flow through blood vessels.

Latest Patents

Michal is credited with 1 patent: “Absorbable Intravascular Stents Having a Therapeutic Drug Within the Scaffold.” The patent describes balloon-expandable, bioresorbable vascular stent elements made with a scaffold and a coating layer containing a bioresorbable structural polymer. A therapeutic drug is provided both in the scaffold coating and within the scaffold’s structural polymer. The disclosed methods also include additive manufacturing for producing the stent.

Career Highlights

Michal’s listed invention combines a bioresorbable stent structure with therapeutic-drug delivery. The design aims to support blood flow while incorporating the drug into both the coating and the scaffold.

Collaborations

Michal is associated with Efemoral Medical Inc. His listed coworkers include Lewis B. Schwartz and Ivan Tzvetanov.

Conclusion

Eugene Michal’s patent reflects work on bioresorbable vascular stents that integrate therapeutic drugs into both the coating and scaffold.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…